1-6 of 6
Piero Ruggenenti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes

Open Access
Piero Ruggenenti, MD, Esteban L. Porrini, MD, Flavio Gaspari, CHEMD, Nicola Motterlini, STATSCID, Antonio Cannata, CHEMIST, Fabiola Carrara, CHEMIST, Claudia Cella, PHARMCHEMD, Silvia Ferrari, CHEMIST, Nadia Stucchi, CHEMIST, Aneliya Parvanova, MD, Ilian Iliev, MD, Alessandro Roberto Dodesini, MD, Roberto Trevisan, MD, Antonio Bossi, MD, Jelka Zaletel, MD, Giuseppe Remuzzi, MD, for the GFR Study Investigators
Journal: Diabetes Care
Diabetes Care 2012;35(10):2061–2068
https://doi.org/10.2337/dc11-2189
Published: 11 September 2012
View articletitled, Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
Open the PDF for Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A Prospective Randomized Double-Blind Clinical Trial: Response to Sarigianni, Katsiki, and Mikhailidis

Open Access
Piero Ruggenenti, MD, Annalisa Perna, STATSCID, Giuseppe Remuzzi, MD, FRCP, for the Ezetimibe and Simvastatin in dyslipidemia of Diabetes (ESD) Study Investigators
Journal: Diabetes Care
Diabetes Care 2010;33(10):e133
https://doi.org/10.2337/dc10-1412
Published: 01 October 2010
View articletitled, Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A Prospective Randomized Double-Blind Clinical Trial: Response to Sarigianni, Katsiki, and Mikhailidis
Open the PDF for Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A Prospective Randomized Double-Blind Clinical Trial: Response to Sarigianni, Katsiki, and Mikhailidis in another window
Includes: Supplementary data
Journal Articles

Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A prospective randomized double-blind clinical trial

Open Access
Piero Ruggenenti, MD, Dario Cattaneo, PHD, Stefano Rota, MD, Ilian Iliev, MD, Aneliya Parvanova, MD, Olimpia Diadei, CHEMD, Bogdan Ene-Iordache, ENGD, Silvia Ferrari, CHEMIST, Antonio C. Bossi, MD, Roberto Trevisan, MD, Antonio Belviso, MD, Giuseppe Remuzzi, MD, FRCP, for the Ezetimibe and Simvastatin in Dyslipidemia of Diabetes (ESD) Study Group
Journal: Diabetes Care
Diabetes Care 2010;33(9):1954–1956
https://doi.org/10.2337/dc10-0320
Published: 21 June 2010
View articletitled, Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A prospective randomized double-blind clinical trial
Open the PDF for Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A prospective randomized double-blind clinical trial in another window
Includes: Supplementary data
Journal Articles

Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)

Free
Piero Ruggenenti, MD, Ilian Iliev, MD, Grazia Maria Costa, MD, Aneliya Parvanova, MD, Annalisa Perna, STAT SCI D, Giovanni Antonio Giuliano, DIPL STAT, Nicola Motterlini, STAT SCI D, Bogdan Ene-Iordache, ENG D, Giuseppe Remuzzi, MD, FRCP, the BENEDICT Study Group
Journal: Diabetes Care
Diabetes Care 2008;31(8):1629–1634
https://doi.org/10.2337/dc08-0371
Published: 01 August 2008
View articletitled, Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)
Open the PDF for Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) in another window
Includes: Supplementary data
Journal Articles

Renal and Metabolic Effects of Insulin Lispro in Type 2 Diabetic Subjects With Overt Nephropathy

Free
Piero Ruggenenti, MD, Claudio Flores, MD, Claudio Aros, MD, Bogdan Ene-Iordache, ENG.D, Roberto Trevisan, MD, Cosimo Ottomano, MD, Giuseppe Remuzzi, MD
Journal: Diabetes Care
Diabetes Care 2003;26(2):502–509
https://doi.org/10.2337/diacare.26.2.502
Published: 01 February 2003
View articletitled, Renal and Metabolic Effects of Insulin Lispro in Type 2 Diabetic Subjects With Overt Nephropathy
Open the PDF for Renal and Metabolic Effects of Insulin Lispro in Type 2 Diabetic Subjects With Overt Nephropathy in another window
Journal Articles

Hyperhomocysteinemia and Increased Risk of Retinopathy: A cross-sectional, case-control study in patients with type 2 diabetes

Free
Aneliya Parvanova, MD, Ilian Iliev, MD, Borislav D. Dimitrov, MD, MSc, Federica Arnoldi, Res Nurse, Jelka Zaletel, MD, Giuseppe Remuzzi, MD, FRCP, Piero Ruggenenti, MD
Journal: Diabetes Care
Diabetes Care 2002;25(12):2361
https://doi.org/10.2337/diacare.25.12.2361
Published: 01 December 2002
View articletitled, Hyperhomocysteinemia and Increased Risk of Retinopathy: A cross-sectional, case-control study in patients with type 2 diabetes
Open the PDF for Hyperhomocysteinemia and Increased Risk of Retinopathy: A cross-sectional, case-control study in patients with type 2 diabetes in another window